Navigation Links
OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation

orexigen.com/">http://www.orexigen.com.

Forward-Looking Statements

Orexigen cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by Orexigen that any of its plans will be achieved. For example, statements regarding the potential progress and results of clinical trials and the use of funds to support such trials may be forward looking statements. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in Orexigen's business, including, without limitation: Orexigen's clinical trials may not proceed in the timeframes or in the manner Orexigen expects or at all; the results of earlier clinical trials may not be predictive of future results; the scientific theories relating to the central nervous system on which Orexigen has based its development programs may not result in product candidates with sufficient efficacy or safety to obtain regulatory approval or commercial success; Orexigen and its licensors may not be able to obtain, maintain and successfully enforce adequate patent and other intellectual property protection of its product candidates; and other risks detailed in Orexigen's public filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and Orexigen undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

     CONTACTS:

     Graham Cooper         Media:                        Investors:

     Orexigen CFO 
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Post Your Comments:
(Date:5/27/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/s9qx9j/asia_pacific_open ) ... Open System MRI Market - Growth, Trends And ... offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... the fastest growing market for Open System MRI. ... replacing CT because of its higher sensitivity and ...
(Date:5/27/2015)... , May 27, 2015  With all the daily ... services they provide to keep patients healthy should be ... effect of the Affordable Care Act continues to affect ... payer partners, making it more important than ever that ... with those they contract with for patient care. ...
(Date:5/27/2015)... May 26, 2015 Research and Markets( http://www.researchandmarkets.com/research/nt9zlx/asia_pacific ... Pacific Mammography Market - Growth, Trends And Forecasts (2014 ... Mammography is a detailed type of imaging that ... mammography exam, called a mammogram, is used to support ... in women. An x-ray (radiograph) is a noninvasive medical ...
Breaking Medicine Technology:Asia Pacific Open System MRI Market Trends and Forecasts 2015-2019 2Physicians Seek Payer Inclusion, Not Impediment 2Physicians Seek Payer Inclusion, Not Impediment 3Asia Pacific Mammography Market Trends and Forecasts 2015-2019 2
... 2011 Amgen (NASDAQ: AMGN ) will present ... 2011 at the Four Seasons Hotel, Boston, Mass., beginning at ... Relations at Amgen, will present. Live audio of the presentation ... www.amgen.com , under Investors. About ...
... 2011 Sigma-Aldrich Corporation (NASDAQ: SIAL ) ... September: KeyBanc Capital Markets 2011 Basic ... the InterContinental, Boston, MA, presenting at 9:00 AM (Eastern). ... 14, at the Grand Hyatt, New York, NY, presenting ...
Cached Medicine Technology:Sigma-Aldrich Corporation to Present at Upcoming Investor Conferences 2
(Date:5/27/2015)... Diego, CA (PRWEB) May 27, 2015 ... and teleradiology services, is pleased to introduce Mr. Chris ... Mr. Hafey has a proven track record of leading ... healthcare information technology domain. He most recently served as ... previously held the role of Chief Architect for Vital ...
(Date:5/27/2015)... As the U.S. Supreme Court considers ... under the Affordable Care Act (ACA), an investigation by ... the RAND Corporation and Express Scripts provides an unprecedented ... initial enrollees. , The analysis is published online ... will also appear in the journal’s June issue. , ...
(Date:5/27/2015)... The BBB Code of Business Practices represents ... customer trust and confidence in business. The Code is ... that summarize important elements of creating and maintaining trust ... accreditation by BBB. Businesses based in the United States ... procedures will be accredited by BBB. , To be ...
(Date:5/27/2015)... New York, New York (PRWEB) May 27, 2015 ... http://www.risperdallawsuit2014.com/ ) filed on behalf of individuals ... other complications related to the use of the ... mass tort litigation currently underway in Pennsylvania’s Philadelphia ... the litigation is proceeding with its bellwether trial ...
(Date:5/27/2015)... While hair transplantation has been used ... pilot study conducted by a physician member of the ... hair follicle grafting can help treat patients with non-healing ... by ISHRS, which offers research grants for the purpose ... , In the past decade, numerous scientific studies have ...
Breaking Medicine News(10 mins):Health News:StatRad Introduces Mr. Chris E. Hafey as Chief Technology Officer, and the Release of its Advanced Pure HTML5 DICOM Image Uploader 2Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 2Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 3Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 4Health News:Carson Energy Receives A+ Accredited Rating For 19 Consecutive Years 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 3Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 3
... redefine traditional notions of aging ... through friendship and fun, FULLERTON, Calif., April 25 ... invisibility. Thanks,to the Red Hat Society (RHS), founded 10 years ago today, ... few friends who donned,red hats and purple outfits in the spirit of ...
... April 24 Amneal Pharmaceuticals, LLC is,pleased to ... for,Amneal,s wholly-owned subsidiary, Amneal Pharmaceuticals of New York, ... Interpharm. The,acquisition includes Interpharm,s facilities on Long Island, ... ANDA,s, technology and,processes., Amneal will use its ...
... at best cost, study says , , THURSDAY, April 24 ... patients in the United States are being referred for ... to physicians who refer patients to their own facilities ... For the study, Dr. Jean M. Mitchell, a professor ...
... difference in survival when compared to expensive lab tests ... switching to a second-line series of drugs for HIV/AIDS ... made on the basis of sophisticated and expensive lab ... is only slightly affected if these decisions are based ...
... Coalition for 21st,Century Medicine (http://www.twentyfirstcenturymedicine.org ), ... innovative diagnostic technology,companies, clinical laboratories, venture capitalists, ... on the passage of the Genetic,Information Nondiscrimination ... morning., The House of Representatives passed ...
... $225,000, CHICAGO, April 24 Many people think ... often grossly,underestimate their future health care costs. Many also ... Medicare and their employers during their,golden years. However, this ... offering retiree health benefits is steadily declining and the,financial ...
Cached Medicine News:Health News:Hats Off to the Red Hat Society, Which Turns 10 Today 2Health News:Hats Off to the Red Hat Society, Which Turns 10 Today 3Health News:Agreement Executed for Amneal Pharmaceuticals to Acquire the Assets of Interpharm Holdings 2Health News:Increase in Diagnostic Imaging Fueled by Self-Referring Doctors 2Health News:Clinical Symptoms Enough to Switch Drug Regimens for HIV Patients 2Health News:Clinical Symptoms Enough to Switch Drug Regimens for HIV Patients 3Health News:Coalition for 21st Century Medicine Congratulates U.S. Senate on Passage of Genetic Information Nondiscrimination Act 2Health News:Health Insurance a Key Component in Financial Planning 2
Proven and Efficient Stand-Alone Device. Offers a choice between alternate breath and every breath delivery. This model provides alternate breath delivery....
Lightweight Pneumatic Conserver., ,NOTE: All models passed the ASTM PS 127-00 regulator ignition safety test....
Lightweight Pneumatic Conserver., ,NOTE: All models passed the ASTM PS 127-00 regulator ignition safety test....
... An All-In-One Conserver., ,Offers an average 5:1 ... ,Allows the use of a standard cannula. ... and lightweight cylinders offers ambulatory oxygen patients a ... backed by a 2-year warranty. ...
Medicine Products: